BWAY Financials: BrainsWay Ltd. AI Analysis

Home

Stock

BWAY

Financials

BWAY Financial

BrainsWay Ltd.

$13.86

2.66%

$0.35

At close: Mar 25, 16:00:00 GMT-4

$13.86

Post-market: Mar 25, 19:34:21 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$13.5

Open

$13.7

Day's Range

$13.55 - $14.05

52 week range

$3.92 - $14.65

Volume

156.1K

Avg.Volume

207.4K

Dividend yield

EPS (TTM)

0.32

Market Cap

$271.8M

What is Brainsway Ltd.?

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

BWAY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	49	41	31	27	29	22
Revenue Growth (YoY)	28.99%	32%	15%	-7%	32%	-4%
Cost of Revenue	12	10	8	7	6	5
Gross Profit	36	30	23	20	23	17
Selling, General & Admin	24	21	21	24	21	15
Research & Development	9	6	6	7	6	5
Operating Expenses	33	29	28	32	28	21
Other Non Operating Income (Expenses)	--	0	-1	0	-1	0
Pretax Income	6	3	-3	-13	-6	-5
Income Tax Expense	0	0	0	0	0	0
Net Income	6	2	-4	-13	-6	-5
Net Income Growth	500%	-150%	-69%	117%	20%	-50%
Shares Outstanding (Diluted)	39.15	34.76	33.15	32.98	31.15	22.45
Shares Change (YoY)	17%	5%	1%	6%	39%	9%
EPS (Diluted)	0.14	0.08	-0.12	-0.4	-0.21	-0.24
EPS Growth	243%	-166%	-68%	90%	-13%	-52%
Free Cash Flow	18	6	-1	-9	-1	-3
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	73.46%	73.17%	74.19%	74.07%	79.31%	77.27%
Operating Margin	4.08%	2.43%	-12.9%	-44.44%	-17.24%	-18.18%
Profit Margin	12.24%	4.87%	-12.9%	-48.14%	-20.68%	-22.72%
Free Cash Flow Margin	36.73%	14.63%	-3.22%	-33.33%	-3.44%	-13.63%
EBITDA	3	2	-3	-11	-4	-2
EBITDA Margin	6.12%	4.87%	-9.67%	-40.74%	-13.79%	-9.09%
D&A For EBITDA	1	1	1	1	1	2
EBIT	2	1	-4	-12	-5	-4
EBIT Margin	4.08%	2.43%	-12.9%	-44.44%	-17.24%	-18.18%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are BrainsWay Ltd.'s key financial statements?



According to the latest financial statement (Form-10K), BrainsWay Ltd. has a total asset of $94, Net profit of $2

What are the key financial ratios for BWAY?



BrainsWay Ltd.'s Current ratio is 2.93, has a Net margin is 4.87, sales per share of $1.17.

How is BrainsWay Ltd.'s revenue broken down by segment or geography?



BrainsWay Ltd. largest revenue segment is Medical Devices, at a revenue of 82,965,688 in the most earnings release.For geography, United States is the primary market for BrainsWay Ltd., at a revenue of 122,995,624.

Is BrainsWay Ltd. profitable?



yes, according to the latest financial statements, BrainsWay Ltd. has a net profit of $2

Does BrainsWay Ltd. have any liabilities?



yes, BrainsWay Ltd. has liability of 32

How many outstanding shares for BrainsWay Ltd.?



BrainsWay Ltd. has a total outstanding shares of 37.62

BrainsWay Ltd. (BWAY) Financial

BWAY Stock Price Chart